United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1837_665f7293-1792-4b57-b8af-3e1fc33e8200
- Product NDC
- 70771-1837
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230518
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1837-0) · 70771-1837-0
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1837-3) · 70771-1837-3
- 10 BLISTER PACK in 1 CARTON (70771-1837-4) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70771-1837-2) · 70771-1837-4
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1837-5) · 70771-1837-5
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1837-9) · 70771-1837-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →